Please Wait.....
Report
Asia-Pacific Nucleic Acid Isolation and Purification Market
Market Report I 2025-05-01 I 350 Pages I Data Bridge Market Research
The Asia-Pacific nucleic acid isolation and purification market is expected to reach USD 3.21 billion by 2032 from USD 1.38 billion in 2024, growing at a CAGR of 11.7% in the forecast period of 2025 to 2032.
Market Segmentation:
Asia-Pacific Nucleic Acid Isolation and Purification Market, By Product (Instruments, Kits, and Reagents), Method (Magnetic Bead-Based Isolation and Purification, Column -Based Isolation and Purification, Reagent-Based Isolation and Purification, and Others), Type (Next Generation Sequencing (NGS), Genomic DNA Isolation and Purification, Total RNA Isolation and Purification, PCR Clean-Up, Plasmid DNA Isolation and Purification, Messenger RNA Isolation and Purification, Circulating Nucleic Acid Isolation and Purification, MicroRNA Isolation and Purification and Others), Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture and Animal Research, and Others), Sample Type (FFPE Samples, Blood Cells, Bacteria, Yeast, and Plants, Cell-Free Samples, Cultured Cells, Mammalian Cells, Brain and Kidney Tissue, and Others), End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Contract Development and manufacturing Organization (CDMO), Academic/Research Institutes, and Others), Country (China, Japan, India, South Korea, Australia, Singapore, Indonesia, Thailand, Malaysia, Philippines, New Zealand, Vietnam, Taiwan, and Rest of Asia-Pacific) - Industry Trends & Forecast To 2032
Overview of the Asia-Pacific Nucleic Acid Isolation and Purification Market Dynamics
Driver
- Increasing Prevalence Of Genetic Disorders
Restraint
- Risks Associated With Sample Contamination
Opportunity
- Rise In Technological Advancements and Automation
Market Players:
The key market players for Asia-Pacific nucleic acid isolation and purification market are listed below:
- Merck KGaA
- Cytiva (Danaher Corporation)
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- Illumina Inc.
- PerkinElmer
- Meridian Bioscience, Inc.
- QIAGEN
- Takara Bio Inc.
- MACHEREY-NAGEL GmbH & Co. KG
- Promega Corporation
- New England Biolabs
- Kurabo Industries Ltd.
- Omega Bio-tek, Inc.
- Zymo Research Corporation
- Analytik Jena GmbH+Co. KG
- LGC Biosearch Technologies
- Daan Gene Co., Ltd.
- MagGenome Technologies Pvt. Ltd.
- TIANGEN BIOTECH (BEIJING) CO., LTD.
TABLE OF CONTENTS
1 INTRODUCTION 98
1.1 OBJECTIVES OF THE STUDY 98
1.2 MARKET DEFINITION 98
1.3 OVERVIEW OF ASIA-PACIFIC NUCLEIC ACID ISOLATION AND PURIFICATION MARKET 98
1.4 MARKETS COVERED 102
2 MARKET SEGMENTATION 106
2.1 MARKETS COVERED 106
2.2 GEOGRAPHICAL SCOPE 107
2.3 YEARS CONSIDERED FOR THE STUDY 108
2.4 CURRENCY AND PRICING 108
2.5 DBMR TRIPOD DATA VALIDATION MODEL 109
2.6 MULTIVARIATE MODELLING 112
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 113
2.8 DBMR MARKET POSITION GRID 114
2.9 VENDOR SHARE ANALYSIS 115
2.10 MARKET END USER COVERAGE GRID 116
2.11 SECONDARY SOURCES 117
2.12 ASSUMPTIONS 117
3 EXECUTIVE SUMMARY 118
4 PREMIUM INSIGHT 125
4.1 PORTER'S FIVE FORCES 126
4.2 PESTEL ANALYSIS 127
4.3 DEFINITION AND IMPORTANCE OF TARIFFS IN THE HEALTHCARE SECTOR 128
5 ASIA-PACIFIC NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: REGULATIONS 134
5.1 REGULATORY AUTHORITIES IN THE ASIA-PACIFIC REGION 134
5.2 NORTH AMERICA REGULATORY SCENARIO 139
5.3 EUROPE REGULATORY SCENARIO 144
5.4 REGULATORY SUBMISSIONS 146
6 MARKET OVERVIEW 157
6.1 DRIVERS 159
6.1.1 INCREASING PREVALENCE OF GENETIC DISORDERS 159
6.1.2 INCREASING DEMAND FOR DIAGNOSTIC TESTING 161
6.1.3 RISING INVESTMENT IN GENOMICS RESEARCH 162
6.1.4 INCREASE IN LAUNCH OF DIAGNOSTIC PRODUCTS 163
6.2 RESTRAINTS 164
6.2.1 RISKS ASSOCIATED WITH SAMPLE CONTAMINATION 164
6.2.2 HIGH COST OF EQUIPMENT AND REAGENTS 165
6.3 OPPORTUNITIES 166
6.3.1 RISE IN TECHNOLOGICAL ADVANCEMENTS AND AUTOMATION 166
6.3.2 INCREASING ADOPTION OF NEXT-GENERATION SEQUENCING (NGS) 167
6.3.3 GROWING APPLICATIONS OF LIQUID BIOPSY IN NON-INVASIVE DIAGNOSTICS 168
6.4 CHALLENGES 170
6.4.1 TECHNICAL DIFFICULTIES IN NUCLEIC ACID ISOLATION ACROSS DIFFERENT SAMPLE TYPES 170
6.4.2 ENVIRONMENTAL AND SUSTAINABILITY CONCERNS 171
7 ASIA-PACIFIC NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE 172
7.1 OVERVIEW 173
7.2 NEXT GENERATION SEQUENCING (NGS) 177
7.3 GENOMIC DNA ISOLATION AND PURIFICATION 177
7.4 TOTAL RNA ISOLATION AND PURIFICATION 178
7.5 PCR CLEAN-UP 178
7.6 PLASMID DNA ISOLATION AND PURIFICATION 179
7.7 MESSENGER RNA ISOLATION AND PURIFICATION 179
7.8 CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION 180
7.9 MICRORNA ISOLATION AND PURIFICATION 180
7.10 OTHERS 181
8 ASIA-PACIFIC NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT 182
8.1 OVERVIEW 183
8.2 INSTRUMENTS 186
8.2.1 HOMOGENIZER 187
8.2.2 SPECTROPHOTOMETERS 187
8.2.3 FLUOROMETERS 187
8.2.4 OTHERS 187
8.2.4.1 Benchtop 188
8.2.4.2 Standalone 188
8.2.4.2.1 Automated 188
8.2.4.2.2 Manual 188
8.3 KITS 188
8.3.1 DNA ISOLATION & PURIFICATION KITS 189
8.3.2 RNA ISOLATION & PURIFICATION KITS 189
8.3.3 VIRAL NUCLEIC ACID ISOLATION KITS 189
8.3.4 PLASMID PURIFICATION KIT 189
8.3.5 PCR AND GEL KIT 189
8.3.6 OTHERS 190
8.3.6.1 MAGNETIC BEAD-BASED KIT 190
8.3.6.2 COLUMN-BASED KIT 190
8.3.6.3 REAGENT-BASED KIT 190
8.3.6.3.1 VIRAL/PATHOGEN NUCLEIC ACID ISOLATION KIT 191
8.3.6.3.2 PLANT DNA ISOLATION KIT 191
8.3.6.3.3 CELL-FREE TOTAL NUCLEIC ACID KIT 191
8.3.6.3.4 CELL-FREE DNA ISOLATION KIT 191
8.3.7 GENOMIC DNA PURIFICATION KIT 193
8.3.8 VIRAL RNA/DNA PURIFICATION KIT 193
8.3.9 PLANT DNA PURIFICATION KIT 193
8.3.10 MICROBIOME DNA PURIFICATION KIT 193
8.3.11 OTHERS 193
8.3.12 MAGNETIC BEAD-BASED KIT 193
8.3.13 COLUMN-BASED KIT 193
8.3.14 REAGENT-BASED KIT 193
8.3.15 VIRAL/PATHOGEN NUCLEIC ACID ISOLATION KIT 195
8.3.16 MRNA PURIFICATION KIT 195
8.3.17 PLANT RNA ISOLATION KIT 195
8.3.18 CELL-FREE NUCLEIC ACID ISOLATION KIT 195
8.3.19 OTHERS 195
8.3.20 RNA ISOLATION KIT 196
8.3.21 MI RNA ISOLATION KIT 196
8.3.22 VIRAL RNA/DNA KIT 196
8.3.23 MAGNETIC BEAD-BASED KITS 197
8.3.24 VIRAL SPIN-COLUMN KITS 197
8.4 REAGENTS 197
8.4.1 DNA ISOLATION REAGENT 198
8.4.2 RNA ISOLATION REAGENT 198
8.4.3 OTHERS 198
9 ASIA-PACIFIC NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE 199
9.1 OVERVIEW 200
9.2 FFPE SAMPLES 203
9.3 BLOOD CELLS 203
9.4 BACTERIA, YEAST, AND PLANTS 204
9.5 CELL-FREE SAMPLES 204
9.6 CULTURED CELLS 205
9.7 MAMMALIAN CELLS 205
9.8 BRAIN AND KIDNEY TISSUE 206
9.9 OTHERS 206
10 ASIA-PACIFIC NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD 207
10.1 OVERVIEW 208
10.2 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION 211
10.3 COLUMN -BASED ISOLATION AND PURIFICATION 211
10.4 REAGENT-BASED ISOLATION AND PURIFICATION 212
10.5 OTHERS 212
11 ASIA-PACIFIC NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION 213
11.1 OVERVIEW 214
11.2 DIAGNOSTICS 217
11.2.1 INSTRUMENTS 217
11.2.2 KITS 217
11.2.3 REAGENTS 217
11.3 DRUG DISCOVERY AND DEVELOPMENT 218
11.3.1 INSTRUMENTS 218
11.3.2 KITS 218
11.3.3 REAGENTS 218
11.4 PERSONALIZED MEDICINE 219
11.4.1 INSTRUMENTS 219
11.4.2 KITS 219
11.4.3 REAGENTS 219
11.5 AGRICULTURE AND ANIMAL RESEARCH 220
11.5.1 INSTRUMENTS 220
11.5.2 KITS 220
11.5.3 REAGENTS 220
11.6 OTHERS 221
12 ASIA-PACIFIC NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER 222
12.1 OVERVIEW 223
12.2 HOSPITALS AND DIAGNOSTIC CENTERS 226
12.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 226
12.4 CONTRACT RESEARCH ORGANIZATIONS 227
12.5 CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CDMO) 227
12.6 ACADEMIC/RESEARCH INSTITUTES 228
12.7 OTHERS 228
13 ASIA-PACIFIC NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION 229
13.1 ASIA-PACIFIC 231
13.1.1 CHINA 247
13.1.2 JAPAN 260
13.1.3 INDIA 272
13.1.4 SOUTH KOREA 284
13.1.5 AUSTRALIA 296
13.1.6 SINGAPORE 308
13.1.7 INDONESIA 320
13.1.8 THAILAND 332
13.1.9 MALAYSIA 346
13.1.10 PHILIPPINES 359
13.1.11 NEW ZEALAND 372
13.1.12 VIETNAM 385
13.1.13 TAIWAN 398
13.1.14 REST OF ASIA-PACIFIC 411
14 ASIA-PACIFIC NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY LANDSCAPE 412
14.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 412
15 SWOT ANALYSIS 413
16 COMPANY PROFILE 414
16.1 MERCK KGAA 414
16.1.1 COMPANY SNAPSHOT 414
16.1.2 REVENUE ANALYSIS 414
16.1.3 COMPANY SHARE ANALYSIS 415
16.1.4 PRODUCT PORTFOLIO 415
16.1.5 RECENT DEVELOPMENT 415
16.2 CYTIVA (DANAHER CORPORATION) 416
16.2.1 COMPANY SNAPSHOT 416
16.2.2 REVENUE ANALYSIS 416
16.2.3 COMPANY SHARE ANALYSIS 417
16.2.4 PRODUCT PORTFOLIO 417
16.2.5 RECENT DEVELOPMENTS 418
16.3 AGILENT TECHNOLOGIES, INC. 420
16.3.1 COMPANY SNAPSHOT 420
16.3.2 REVENUE ANALYSIS 420
16.3.3 COMPANY SHARE ANALYSIS 421
16.3.4 PRODUCT PORTFOLIO 421
16.3.5 RECENT DEVELOPMENT 424
16.4 BIO-RAD LABORATORIES, INC. 425
16.4.1 COMPANY SNAPSHOT 425
16.4.2 REVENUE ANALYSIS 425
16.4.3 COMPANY SHARE ANALYSIS 426
16.4.4 PRODUCT PORTFOLIO 426
16.4.5 RECENT DEVELOPMENT 427
16.5 F. HOFFMANN-LA ROCHE LTD 428
16.5.1 COMPANY SNAPSHOT 428
16.5.2 REVENUE ANALYSIS 428
16.5.3 COMPANY SHARE ANALYSIS 429
16.5.4 PRODUCT PORTFOLIO 429
16.5.5 RECENT DEVELOPMENT 429
16.6 ANALYTIK JENA GMBH+CO. KG 430
16.6.1 COMPANY SNAPSHOT 430
16.6.2 PRODUCT PORTFOLIO 430
16.6.3 RECENT DEVELOPMENT 430
16.7 AUTOGEN, INC. 432
16.7.1 COMPANY SNAPSHOT 432
16.7.2 PRODUCT PORTFOLIO 432
16.7.3 RECENT DEVELOPMENT 435
16.8 DAAN GENE CO., LTD. 436
16.8.1 COMPANY SNAPSHOT 436
16.8.2 PRODUCT PORTFOLIO 436
16.8.3 RECENT DEVELOPMENT 438
16.9 HIMEDIA LABORATORIES 439
16.9.1 COMPANY SNAPSHOT 439
16.9.2 PRODUCT PORTFOLIO 439
16.9.3 RECENT DEVELOPMENT 440
16.10 ILLUMINA, INC. 441
16.10.1 COMPANY SNAPSHOT 441
16.10.2 REVENUE ANALYSIS 441
16.10.3 PRODUCT PORTFOLIO 442
16.10.4 RECENT DEVELOPMENT 442
16.11 KURABO INDUSTRIES LTD. 443
16.11.1 COMPANY SNAPSHOT 443
16.11.2 REVENUE ANALYSIS 443
16.11.3 PRODUCT PORTFOLIO 444
16.11.4 RECENT DEVELOPMENT 446
16.12 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD. 447
16.12.1 COMPANY SNAPSHOT 447
16.12.2 REVENUE ANALYSIS 447
16.12.3 PRODUCT PORTFOLIO 448
16.12.4 RECENT DEVELOPMENT 449
16.13 LGC BIOSEARCH TECHNOLOGIES 450
16.13.1 COMPANY SNAPSHOT 450
16.13.2 PRODUCT PORTFOLIO 450
16.13.3 RECENT DEVELOPMENTS 451
16.14 MACHEREY-NAGEL GMBH & CO. KG 452
16.14.1 COMPANY SNAPSHOT 452
16.14.2 PRODUCT PORTFOLIO 452
16.14.3 RECENT DEVELOPMENT 452
16.15 MAGGENOME TECHNOLOGIES PVT. LTD. 453
16.15.1 COMPANY SNAPSHOT 453
16.15.2 PRODUCT PORTFOLIO 453
16.15.3 RECENT DEVELOPMENT 457
16.16 MEDOX BIOTECH INDIA PVT. LTD. 458
16.16.1 COMPANY SNAPSHOT 458
16.16.2 PRODUCT PORTFOLIO 458
16.16.3 RECENT DEVELOPMENT 459
16.17 MERIDIAN BIOSCIENCE, INC. 460
16.17.1 COMPANY SNAPSHOT 460
16.17.2 PRODUCT PORTFOLIO 460
16.17.3 RECENT DEVELOPMENT 460
16.18 NEW ENGLAND BIOLABS 461
16.18.1 COMPANY SNAPSHOT 461
16.18.2 PRODUCT PORTFOLIO 461
16.18.3 RECENT DEVELOPMENT 462
16.19 NORGEN BIOTEK CORP. 463
16.19.1 COMPANY SNAPSHOT 463
16.19.2 PRODUCT PORTFOLIO 463
16.19.3 RECENT DEVELOPMENT 464
16.20 OMEGA BIO-TEK, INC. 465
16.20.1 COMPANY SNAPSHOT 465
16.20.2 PRODUCT PORTFOLIO 465
16.20.3 RECENT DEVELOPMENT 467
16.21 PCR BIOSYSTEMS 468
16.21.1 COMPANY SNAPSHOT 468
16.21.2 PRODUCT PORTFOLIO 468
16.21.3 RECENT DEVELOPMENT 468
16.22 PERKINELMER 469
16.22.1 COMPANY SNAPSHOT 469
16.22.2 REVENUE ANALYSIS 469
16.22.3 PRODUCT PORTFOLIO 470
16.22.4 RECENT DEVELOPMENT 470
16.23 PROMEGA CORPORATION 471
16.23.1 COMPANY SNAPSHOT 471
16.23.2 PRODUCT PORTFOLIO 471
16.23.3 RECENT DEVELOPMENT 471
16.24 QIAGEN 472
16.24.1 COMPANY SNAPSHOT 472
16.24.2 REVENUE ANALYSIS 472
16.24.3 PRODUCT PORTFOLIO 473
16.24.4 RECENT DEVELOPMENTS/NEWS 474
16.25 SAGE SCIENCE, INC. 475
16.25.1 COMPANY SNAPSHOT 475
16.25.2 PRODUCT PORTFOLIO 475
16.25.3 RECENT DEVELOPMENTS 475
16.26 TAKARA BIO INC. 477
16.26.1 COMPANY SNAPSHOT 477
16.26.2 REVENUE ANALYSIS 477
16.26.3 PRODUCT PORTFOLIO 478
16.26.4 RECENT DEVELOPMENTS 478
16.27 THERMO FISHER SCIENTIFIC INC. 479
16.27.1 COMPANY SNAPSHOT 479
16.27.2 REVENUE ANALYSIS 479
16.27.3 PRODUCT PORTFOLIO 480
16.27.4 RECENT DEVELOPMENT 483
16.28 TIANGEN BIOTECH (BEIJING) CO.,LTD. 485
16.28.1 COMPANY SNAPSHOT 485
16.28.2 PRODUCT PORTFOLIO 485
16.28.3 RECENT DEVELOPMENT 485
16.29 XI'AN TIANLONG SCIENCE AND TECHNOLOGY CO., LTD 486
16.29.1 COMPANY SNAPSHOT 486
16.29.2 PRODUCT PORTFOLIO 486
16.29.3 RECENT DEVELOPMENT 487
16.30 ZYMO RESEARCH CORPORATION 488
16.30.1 COMPANY SNAPSHOT 488
16.30.2 PRODUCT PORTFOLIO 488
16.30.3 RECENT DEVELOPMENT 489
17 QUESTIONNAIRE 490
18 RELATED REPORTS 494
?
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security